{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T18:55:28Z","timestamp":1761418528117},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2008,3,29]],"date-time":"2008-03-29T00:00:00Z","timestamp":1206748800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s00347-008-1694-2","type":"journal-article","created":{"date-parts":[[2008,3,27]],"date-time":"2008-03-27T11:53:46Z","timestamp":1206618826000},"page":"1023-1028","source":"Crossref","is-referenced-by-count":8,"title":["Diagnostik und Behandlung der okul\u00e4ren Toxoplasmose"],"prefix":"10.1007","volume":"105","author":[{"given":"N.","family":"Torun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Sherif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Garweg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Pleyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,29]]},"reference":[{"key":"1694_CR1","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1136\/bjo.82.8.858","volume":"82","author":"Bosch-Driessen","year":"1998","unstructured":"Bosch-Driessen LE, Rothova A (1998) Sense and nonsense of corticosteroid administration in the treatment of ocular toxoplasmosis. Br J Ophthalmol 82: 858\u2013860","journal-title":"Br J Ophthalmol"},{"key":"1694_CR2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0161-6420(02)00990-9","volume":"109","author":"Bosch-Driessen","year":"2002","unstructured":"Bosch-Driessen LH, Berendschott TT, Ongkosuwito JV, Rothova A (2002) Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology 109: 869\u2013878","journal-title":"Ophthalmology"},{"key":"1694_CR3","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0002-9394(14)73706-7","volume":"111","author":"Engstrom","year":"1991","unstructured":"Engstrom R, Holland GN, Nussenblatt RB, Jabs DA (1991) Current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 111: 601\u2013610","journal-title":"Am J Ophthalmol"},{"key":"1694_CR4","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1001\/archopht.1962.00960020712004","volume":"67","author":"Fajardo","year":"1962","unstructured":"Fajardo RV, Furgiuele FP, Leopold IH (1962) Treatment of toxoplasmosis uveitis. Arch Ophthalmol 67: 712\u2013720","journal-title":"Arch Ophthalmol"},{"key":"1694_CR5","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1128\/JCM.38.3.996-1001.2000","volume":"38","author":"Garweg","year":"2000","unstructured":"Garweg JG, Jacquier P, Boehnke M. (2000) Early aqueous humor analysis in patients with human ocular toxoplasmosis. J Clin Microbiol 38: 996\u20131001","journal-title":"J Clin Microbiol"},{"key":"1694_CR6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-3024.2005.00747.x","volume":"27","author":"Garweg","year":"2005","unstructured":"Garweg JG (2005) Determinants of immunodiagnostic success in human ocular toxoplasmosis. Parasite Immunol 27: 61\u201368","journal-title":"Parasite Immunol"},{"key":"1694_CR7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0002-9394(02)01526-X","volume":"134","author":"Holland","year":"2002","unstructured":"Holland GN, Lewis KG (2002) An update on current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 134(1): 102\u2013114","journal-title":"Am J Ophthalmol"},{"key":"1694_CR8","first-page":"973","volume":"Ophthalmol136","author":"Holland","year":"2003","unstructured":"Holland GN (2003) Ocular toxoplasmosis: a global reassessment. Part I: Epidemiology and course of disease. Am J Ophthalmol136: 973\u2013988","journal-title":"Am J"},{"key":"1694_CR9","first-page":"1","volume":"Ophthalmol137","author":"Holland","year":"2004","unstructured":"Holland GN (2004) Ocular toxoplasmosis: A global reassessment. Part II: Disease manifestations and management. Am J Ophthalmol137: 1\u201317","journal-title":"Am J"},{"key":"1694_CR10","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.ophtha.2005.09.026","volume":"112","author":"Holland","year":"2005","unstructured":"Holland GN (2005) Prospective randomized trial of trimethoprim\/sulfamethoxazole vs. pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis: discussion. Ophthalmology 112: 1882\u20131884","journal-title":"Ophthalmology"},{"key":"1694_CR11","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/0002-9394(61)90741-3","volume":"52","author":"Kaufman","year":"1961","unstructured":"Kaufman HE (1961) The penetration of daraprim (pyrimethamine) into monkey eye. Am J Ophthalmol 52: 402\u2013404","journal-title":"Am J Ophthalmol"},{"key":"1694_CR12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0002-9394(83)90378-1","volume":"95","author":"Lakhanpal","year":"1983","unstructured":"Lakhanpal V, Schocket SS, Nirankari VS (1983) Clindamycin in the treatment of toxoplasmic retinochoroiditis. Am J Ophthalmol 95: 605\u2013613","journal-title":"Am J Ophthalmol"},{"key":"1694_CR13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0002-9394(14)70532-X","volume":"121","author":"McCannel","year":"1996","unstructured":"McCannel CA, Holland GN, Helm CJ, Cornell PJ, Winston JV, Rimmer TG (1996) Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group. Am J Ophthalmol 121: 35\u201346","journal-title":"Am J Ophthalmol"},{"key":"1694_CR14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0002-9394(99)00266-4","volume":"128","author":"Ongkosuwito","year":"1999","unstructured":"Ongkosuwito JV, Bosch-Driessen EH, Kijlstra A, Rothova A (1999) Serologic evaluation of patients with primary and recurrent ocular toxoplasmosis for evidence of recent infection. Am J Ophthalmol 128: 407\u2013412","journal-title":"Am J Ophthalmol"},{"key":"1694_CR15","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/bjo.80.12.1099","volume":"80","author":"Pavesio","year":"1996","unstructured":"Pavesio CE, Lightman S (1996) Toxoplasma gondii and ocular toxoplasmosis: pathogenesis. Br J Ophthalmol 80: 1099\u20131107","journal-title":"Br J Ophthalmol"},{"key":"1694_CR16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0161-6420(99)90021-0","volume":"106","author":"Pearson","year":"1999","unstructured":"Pearson PA, Piracha AR, Sen HA, Jaffe GJ (1999) Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients. Ophthalmology 106: 148\u2013153","journal-title":"Ophthalmology"},{"key":"1694_CR17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000309382","volume":"189","author":"Perkins","year":"1984","unstructured":"Perkins ES, Folk J (1984) Uveitis in London and Iowa. Ophthalmologica 189: 36\u201340","journal-title":"Ophthalmologica"},{"key":"1694_CR18","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00347-007-1535-8","volume":"104","author":"Pleyer","year":"2007","unstructured":"Pleyer U, Torun N, Liesenfeld O (2007) Okul\u00e4re Toxplasmose. Ophthalmologe 104(7): 603\u2013615","journal-title":"Ophthalmologe"},{"key":"1694_CR19","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/BF01639009","volume":"7","author":"Reeves","year":"1979","unstructured":"Reeves DS, Wilkinson PJ (1979) The pharmacokinetics of trimethoprim and trimethoprim\/sulphonamide combinations, including penetration into body tissues. Infection 7: 330\u2013341","journal-title":"Infection"},{"key":"1694_CR20","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/bjo.82.11.1306","volume":"82","author":"Rothova","year":"1998","unstructured":"Rothova A, Bosch-Driesen LE, van Loon NH, Treffers WF (1998) Azithromycin for ocular toxoplasmosis. Br J Ophthalmol 82(11): 1306\u20131308","journal-title":"Br J Ophthalmol"},{"key":"1694_CR21","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9394(14)74456-3","volume":"115","author":"Rothova","year":"1993","unstructured":"Rothova A, Meenken C, Buitenhuis HJ, et al. (1993) Therapy for ocular toxoplasmosis. Am J Ophthalmol 115: 517\u2013523","journal-title":"Am J Ophthalmol"},{"key":"1694_CR22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0002-9394(81)90642-5","volume":"92","author":"Sabates","year":"1981","unstructured":"Sabates R, Pruett RC, Brockhurst RJ (1981) Fulminant ocular toxoplasmosis. Am J Ophthalmol 92: 497\u2013503","journal-title":"Am J Ophthalmol"},{"key":"1694_CR23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/bjo.2006.100925","volume":"91","author":"Scherrer","year":"2007","unstructured":"Scherrer J, Iliev ME, Halberstadt M, Kodjikian L, Garweg JG (2007) Visual function in human ocular toxoplasmosis. Br J Ophthalmol 91(2): 233\u2013236","journal-title":"Br J Ophthalmol"},{"key":"1694_CR24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00055735-200212000-00008","volume":"13","author":"Smith","year":"2002","unstructured":"Smith JR, Cunningham ET (2002) Atypical presentations of ocular toxoplasmosis. Curr Opin Ophthalmol 13: 387\u2013392","journal-title":"Curr Opin Ophthalmol"},{"key":"1694_CR25","doi-asserted-by":"crossref","unstructured":"Soheilian M, Sadoughi MM, Ghajarnia M, et al. (2005) Prospective randomized trial of trimethoprim\/ sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis. Ophthalmology112: 1876\u20131882","DOI":"10.1016\/j.ophtha.2005.05.025"},{"key":"1694_CR26","doi-asserted-by":"crossref","unstructured":"Stanford MR, See SE, Jones LV, Gilbert RE (2003) Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review. Ophthalmology110: 926\u2013931","DOI":"10.1016\/S0161-6420(03)00083-6"},{"key":"1694_CR27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0161-6420(80)35268-8","volume":"87","author":"Tabbara","year":"1980","unstructured":"Tabbara KF, O\u2019Connor GR (1980) Treatment of ocular toxoplasmosis with clindamycin and sulfadiazine. Ophthalmology 87:129\u2013134","journal-title":"Ophthalmology"},{"key":"1694_CR28","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF00917833","volume":"18","author":"Tran","year":"1994","unstructured":"Tran VT, Auer C, Guex-Crosier Y et al. (1994) Epidemiological characteristics of uveitis in Switzerland. Int Ophthalmol 18: 293\u2013298","journal-title":"Int Ophthalmol"},{"key":"1694_CR29","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1128\/JCM.41.8.3537-3541.2003","volume":"41","author":"Villard","year":"2003","unstructured":"Villard O, Filisetti D, Roch-Deries F, Garweg J, Flament J, Candolfi E (2003) Comparison of enzyme-linked immunosorbent assay, immunoblotting, and PCR for diagnosis of toxoplasmic chorioretinitis. J Clin Microbiol 41: 3537\u20133541","journal-title":"J Clin Microbiol"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-008-1694-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-008-1694-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-008-1694-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T13:52:56Z","timestamp":1588513976000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-008-1694-2"}},"subtitle":["Eine Bestandsaufnahme unter deutschsprachigen Ophthalmologen"],"short-title":[],"issued":{"date-parts":[[2008,3,29]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["1694"],"URL":"https:\/\/doi.org\/10.1007\/s00347-008-1694-2","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,29]]}}}